Bruker Corporation. (1/2/18). "Press Release: Bruker Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference". Billerica, MA.

	Region	San Francisco, CA
	Country	United States (USA)
	Organisation	Bruker Corporation (Nasdaq: BRKR)
	Group	Bruker (Group)
	Organisation 2	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 36th Annual Healthcare Conference 2018 San Francisco
	Product 2	analytical instrument
	Index term	Bruker–JPMorgan Chase: investor conference, 201801 supply service Bruker presents at JP Morgan Healthcare Conference 2018
	Person	Laukien, Frank H. (Bruker 201204 President + CEO)
	Person 2	Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore)

Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 36th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Tony Mattacchione, Senior Vice President and CFO will present on behalf of the company on Monday, January 8th, 2018 at 10:00 AM Pacific Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's web site at ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nanoanalysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit: www.bruker.com .

Contact:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
miroslava.minkova@bruker.com

Record changed: 2023-06-05